The Univeristy of Liverpool have pioneered a robust, scalable, and automated synthetic platform to develop a new class of antibiotics—synthetic teixobactins. These antibiotics effectively eliminate drug-resistant bacterial pathogens without detectable resistance. Leveraging cost-effective components, our technology offers a compelling solution to antimicrobial resistance, potentially saving millions of lives around the world.
https://www.liverpool.ac.uk/people/ishwar-singh
Take a look at the finalists across the four competition categories
Find out more